| International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma S Kumar, B Paiva, KC Anderson, B Durie, O Landgren, P Moreau, ... The lancet oncology 17 (8), e328-e346, 2016 | 2480 | 2016 |
| Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). MC Bene, G Castoldi, W Knapp, WD Ludwig, E Matutes, A Orfao, ... Leukemia 9 (10), 1783-1786, 1995 | 2240 | 1995 |
| International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data DA Arber, A Orazi, RP Hasserjian, MJ Borowitz, KR Calvo, HM Kvasnicka, ... Blood, The Journal of the American Society of Hematology 140 (11), 1200-1228, 2022 | 1111 | 2022 |
| EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes JJM Van Dongen, L Lhermitte, S Böttcher, J Almeida, ... Leukemia 26 (9), 1908-1975, 2012 | 1039 | 2012 |
| EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols T Kalina, J Flores-Montero, VHJ Van Der Velden, M Martin-Ayuso, ... Leukemia 26 (9), 1986-2010, 2012 | 817 | 2012 |
| Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference P Valent, HP Horny, JM Bennett, C Fonatsch, U Germing, P Greenberg, ... Leukemia research 31 (6), 727-736, 2007 | 730 | 2007 |
| Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal P Valent, C Akin, M Arock, K Brockow, JH Butterfield, MC Carter, ... International archives of allergy and immunology 157 (3), 215-225, 2012 | 683 | 2012 |
| Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders AC Rawstron, A Orfao, M Beksac, L Bezdickova, R Brooimans, H Bumbea, ... haematologica 93 (3), 431-438, 2008 | 655 | 2008 |
| New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis … E Pérez-Persona, MB Vidriales, G Mateo, R García-Sanz, MV Mateos, ... Blood, The Journal of the American Society of Hematology 110 (7), 2586-2592, 2007 | 626 | 2007 |
| Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma J Flores-Montero, L Sanoja-Flores, B Paiva, N Puig, O García-Sánchez, ... Leukemia 31 (10), 2094-2103, 2017 | 587 | 2017 |
| KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on … AC Garcia-Montero, M Jara-Acevedo, C Teodosio, ML Sanchez, R Nunez, ... Blood 108 (7), 2366-2372, 2006 | 575 | 2006 |
| Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies JJM van Dongen, VHJ van der Velden, M Brüggemann, A Orfao Blood, The Journal of the American Society of Hematology 125 (26), 3996-4009, 2015 | 564 | 2015 |
| Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation B Paiva, MB Vidriales, J Cerveró, G Mateo, JJ Pérez, MA Montalbán, ... Blood, The Journal of the American Society of Hematology 112 (10), 4017-4023, 2008 | 513 | 2008 |
| Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment … JF San Miguel, MB Vidriales, C López-Berges, J Dıaz-Mediavilla, ... Blood, The Journal of the American Society of Hematology 98 (6), 1746-1751, 2001 | 429 | 2001 |
| Cutaneous manifestations in patients with mastocytosis: consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma … K Hartmann, L Escribano, C Grattan, K Brockow, MC Carter, ... Journal of Allergy and Clinical Immunology 137 (1), 35-45, 2016 | 419 | 2016 |
| Minimal residual disease in leukaemia patients T Szczepariski, A Orfão, VHJ van der Valden, JF San Miguel, ... The lancet oncology 2 (7), 409-417, 2001 | 406 | 2001 |
| Human peripheral blood B‐cell compartments: a crossroad in B‐cell traffic M Perez‐Andres, B Paiva, WG Nieto, A Caraux, A Schmitz, J Almeida, ... Cytometry Part B: Clinical Cytometry 78 (S1), S47-S60, 2010 | 387 | 2010 |
| Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia P Theunissen, E Mejstrikova, L Sedek, AJ van der Sluijs-Gelling, G Gaipa, ... Blood, The Journal of the American Society of Hematology 129 (3), 347-357, 2017 | 382 | 2017 |
| Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification E Matutes, WF Pickl, M Van'T Veer, R Morilla, J Swansbury, H Strobl, ... Blood, The Journal of the American Society of Hematology 117 (11), 3163-3171, 2011 | 358 | 2011 |
| New criteria for response assessment: role of minimal residual disease in multiple myeloma B Paiva, JJM van Dongen, A Orfao Blood, The Journal of the American Society of Hematology 125 (20), 3059-3068, 2015 | 355 | 2015 |
